Although phototherapy (PT) is a standard treatment for neonatal jaundice, no validated clinical methods for determination of bilirubin phototherapy products are available. Thus, the aim of our study was to establish a such method for clinical use. To achieve this aim, a LC-MS/MS assay for simultaneous determination of Z-lumirubin (LR) and unconjugated bilirubin (UCB) was conducted. LR was purified after irradiation of UCB at 460 nm. The assay was tested on human sera from PT-treated neonates. Samples were separated on a HPLC system with a triple quadrupole mass spectrometer detector. The instrument response was linear up to 5.8 and 23.4 mg/dL for LR and UCB, respectively, with submicromolar limits of detection and validity parameters relevant for use in clinical medicine. Exposure of newborns to PT raised serum LR concentrations three-fold (p < 0.01), but the absolute concentrations were low (0.37 ± 0.16 mg/dL), despite a dramatic decrease of serum UCB concentrations (13.6 ± 2.2 vs. 10.3 ± 3.3 mg/dL, p < 0.01). A LC-MS/MS method for the simultaneous determination of LR and UCB in human serum was established and validated for clinical use. This method should help to monitor neonates on PT, as well as to improve our understanding of both the kinetics and biology of bilirubin phototherapy products.

4th Department of Internal Medicine Faculty General Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Chemistry and Recetox Faculty of Science Masaryk University Brno Czech Republic

Department of Pediatrics and Neonatology Faculty General Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

HPST s r o Prague Czech Republic

Institute of Medical Biochemistry and Laboratory Diagnostics Faculty General Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Bhutani VK, et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106:E17. doi: 10.1542/peds.106.2.e17. PubMed DOI

Fouzas S, Mantagou L, Skylogianni E, Mantagos S, Varvarigou A. Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. Pediatrics. 2010;125:e52–57. doi: 10.1542/peds.2009-0403. PubMed DOI

Newman TB, Easterling MJ, Goldman ES, Stevenson DK. Laboratory evaluation of jaundice in newborns; Frequency,cost, yield. Am. J. Dis. Child. 1990;144:364–368. doi: 10.1001/archpedi.1990.02150270114039. PubMed DOI

Cremer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinemia of infants. Lancet. 1958;i:1094–1097. doi: 10.1016/S0140-6736(58)91849-X. PubMed DOI

Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin. Perinatol. 2004;28:326–333. doi: 10.1053/j.semperi.2004.09.003. PubMed DOI

Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N. Engl. J. Med. 2008;358:920–928. doi: 10.1056/NEJMct0708376. PubMed DOI

Tyson JE, et al. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J. Perinatol. 2012;32:677–684. doi: 10.1038/jp.2012.64. PubMed DOI PMC

Arnold C, Pedroza C, Tyson JE. Phototherapy in ELBW newborns: does it work? Is it safe? The evidence from randomized clinical trials. Semin. Perinatol. 2014;38:452–464. doi: 10.1053/j.semperi.2014.08.008. PubMed DOI

Morris BH, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N. Engl. J. Med. 2008;359:1885–1896. doi: 10.1056/NEJMoa0803024. PubMed DOI PMC

Auger N, Laverdiere C, Ayoub A, Lo E, Luu TM. Neonatal phototherapy and future risk of childhood cancer. Int. J. Cancer. 2019;145:2061–2069. doi: 10.1002/ijc.32158. PubMed DOI

Ramy N, et al. Jaundice, phototherapy and DNA damage in full-term neonates. J. Perinatol. 2016;36:132–136. doi: 10.1038/jp.2015.166. PubMed DOI

Bonnett R, et al. Photobilirubin II. Biochem. J. 1984;219:1053–1056. doi: 10.1042/bj2191053. PubMed DOI PMC

Stoll MS, Vicker N, Gray CH, Bonnett R. Concerning the structure of photobilirubin II. Biochem. J. 1982;201:179–188. doi: 10.1042/bj2010179. PubMed DOI PMC

Stoll MS, Zenone EA, Ostrow JD, Zarembo JE. Preparation and properties of bilirubin photoisomers. Biochem. J. 1979;183:139–146. doi: 10.1042/bj1830139. PubMed DOI PMC

McDonagh AF. Bilirubin photo-isomers: regiospecific acyl glucuronidation in vivo. Monatsh Chem. 2014;145:465–482. doi: 10.1007/s00706-013-1076-6. DOI

McDonagh AF, Palma LA, Trull FR, Lightner DA. Phototherapy for neonatal jaundice. Configurational isomers of bilirubin. J. Am. Chem. Soc. 1982;104:6865–6869. doi: 10.1021/ja00388a103. DOI

Itoh S, Isobe K, Onishi S. Accurate and sensitive high-performance liquid chromatographic method for geometrical and structural photoisomers of bilirubin IX alpha using the relative molar absorptivity values. J. Chromatogr. A. 1999;848:169–177. doi: 10.1016/S0021-9673(99)00469-0. PubMed DOI

McDonagh AF, Assisi F. The ready isomerization of bilirubin IX- in aqueous solution. Biochem. J. 1972;129:797–800. doi: 10.1042/bj1290797. PubMed DOI PMC

Jašprová J, et al. Neuro-inflammatory effects of photodegradative products of bilirubin. Sci. Rep. 2018;8:7444. doi: 10.1038/s41598-018-25684-2. PubMed DOI PMC

Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957;226:497–509. PubMed

Zelenka J, et al. Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues. J. Chrom B Anal. Technol. Biomed. Life Sci. 2008;867:37–42. doi: 10.1016/j.jchromb.2008.03.005. PubMed DOI

Vecka, M. et al. Comprehensive sterol and fatty acid analysis in nineteen nuts, seeds, and kernel. SN Applied Sciences1, 10.1007/s42452-019-1576-z (2019).

Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics114, 297–316 (2004). PubMed

Jasprova J, et al. The biological effects of bilirubin photoisomers. PLoS One. 2016;11:e0148126. doi: 10.1371/journal.pone.0148126. PubMed DOI PMC

Soares DG, Andreazza AC, Salvador M. Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems. J. Agric. Food Chem. 2003;51:1077–1080. doi: 10.1021/jf020864z. PubMed DOI

Reddy AC, Lokesh BR. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol. Cell Biochem. 1992;111:117–124. PubMed

Ebbesen F, et al. Bilirubin isomer distribution in jaundiced neonates during phototherapy with LED light centered at 497 nm (turquoise) vs. 459 nm (blue) Pediatr. Res. 2016;80:511–515. doi: 10.1038/pr.2016.115. PubMed DOI

McDonagh AF. Light effects on transport and excretion of bilirubin in newborns. Ann. NY. Acad. Sci. 1985;453:65–72. doi: 10.1111/j.1749-6632.1985.tb11798.x. PubMed DOI

Efficacy of phototherapy of neonatal jaundice - light wavelength matters

Risk of childhood cancer in infants treated with phototherapy for neonatal jaundice

The Effects of Bilirubin and Lumirubin on the Differentiation of Human Pluripotent Cell-Derived Neural Stem Cells

Diagnostic methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments

The Effects of Bilirubin and Lumirubin on Metabolic and Oxidative Stress Markers

The Extent of Intracellular Accumulation of Bilirubin Determines Its Anti- or Pro-Oxidant Effect

The Role of Bilirubin and the Other "Yellow Players" in Neurodegenerative Diseases